Quantification of antibody levels to SARS-CoV-2 in immunoglobulin replacement therapy products, and their capacity to augment immunity in immunodeficient patients.

  • Edwards, Emily (Primary Chief Investigator (PCI))
  • van Zelm, Menno (Chief Investigator (CI))
  • Ojaimi, Samar (Chief Investigator (CI))
  • Bosco, Julian Joseph (Chief Investigator (CI))
  • O'Hehir, Robyn (Associate Investigator (AI))
  • Drummer, Heidi (Associate Investigator (AI))
  • Hogarth, Mark (Associate Investigator (AI))
  • Daly, James (Associate Investigator (AI))
  • Murphy, Jackie (Associate Investigator (AI))

Project: Research

Project Details

StatusActive
Effective start/end date1/10/22 → 30/09/24

Funding

  • Allergy and Immunology Foundation of Australasia: A$30,000.00

Keywords

  • primary immunodeficiency
  • COVID-19 immunity
  • vaccination responses
  • Ig product
  • COVID-19 antibodies